Contribution of clinical epidemiology to evidence-based nephrology;Apports de l'épidémiologie clinique á la néphrologie basée sur les preuves

Nephrologie

Volumn 22, Issue 5, 2001, Pages 199-203

  Frimat, L ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

Based nephrology; Clinical epidemiology; Diagnosis; Evidence; IgA nephropathy; Methodology; Prognosis

Indexed keywords

DECISION MAKING; EVIDENCE BASED MEDICINE; HEMATURIA; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; MEDICAL PRACTICE; MEDICAL RESEARCH; NEPHROLOGY; PROGNOSIS; REVIEW;

EPIDEMIOLOGY; EVIDENCE-BASED MEDICINE; GLOMERULONEPHRITIS, IGA; HEMATURIA; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; NEPHROLOGY; PROGNOSIS;

EID: 18244426776     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. La médecine factuelle
2. Evidence-based nephrology
3. Evidence-based medicine and «Médecine d'observation»
4. Epidémiologie et évaluation en médecine
5. Le risque en épidémiologie et en santé publique
6. Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies
7. Studying the causes of kidney disease in humans: A review of methodologic obstacles and possible solutions
8. Evidence-based medicine: An approach to clinical problem solving
9. Frequency of mesangial IgA deposits in a non-selected autopsy series
10. Pathogenesis of IgA nephropathy
11. IgA nephropathy: Pronostic classification of end-stage renal failure
12. Polymorphism in the genes for angiotensin converting enzyme, angiotensinogen and angiotensin II type 1 receptor and end-stage renal failure in IgA nephropathy
13. IgA nephropathy in Korea: A morphological and clinical study
14. The risk of determining risk with multivariate models
15. Le modèle de Cox: Limites et extension
16. Data torturing
17. Prognosis of idiopathic membranous nephropathy: A methodologic meta-analysis
18. Decision analysis